Puerarin promotes DUSP1 expression by regulating miR-133a-3p in breast cancer

Previous studies demonstrated that puerarin represents a potential therapeutic drug for breast cancer treatment, due to its ability to inhibit the migration of MCF-7 and MDA-MB-231 cell lines. In order to investigate the mechanism of puerarin in breast cancer cells, the aim of the present study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhifeng, Xu, Weiwei, Ren, Xiaoyan, Xu, Jinhua, Chen, Jianxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297792/
https://www.ncbi.nlm.nih.gov/pubmed/30483784
http://dx.doi.org/10.3892/mmr.2018.9682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297792/
https://www.ncbi.nlm.nih.gov/pubmed/30483784
http://dx.doi.org/10.3892/mmr.2018.9682

Ejemplares similares